BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.

Aldeyra Therapeutics Inc. – Material Contracts

NASDAQ: ALDX    
Share price (8/19/26): $1.58    
Market cap (8/19/26): $95.3 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 15 pages Material contract
12/34/56
EX-10.27
from 10-K 2 pages November 15, 2024 Aldeyra Therapeutics, Inc. 131 Hartwell Avenue, Suite 320 Lexington, Ma 02421 Re: Aldeyra and Reproxalap Commercialization Funding and Option Period Extension to Whom It May Concern
12/34/56
EX-10.1
from 10-Q 3 pages Sixth Amendment to Lease Agreement
12/34/56
EX-10.27
from 10-K 2 pages November 15, 2024 Aldeyra Therapeutics, Inc. 131 Hartwell Avenue, Suite 320 Lexington, Ma 02421 Re: Aldeyra and Reproxalap Commercialization Funding and Option Period Extension to Whom It May Concern
12/34/56
EX-10.4
from 10-Q 7 pages Master Services Agreement 1
12/34/56
EX-10.3
from 10-Q 16 pages Separation Agreement
12/34/56
EX-10.2
from 10-Q 3 pages Fifth Amendment to Lease Agreement
12/34/56
EX-10.26
from 10-K 113 pages Recitals Article 1 Definitions
12/34/56
EX-10.14
from 10-K 4 pages Fourth Amendment to Lease Period Annual Base Rent Monthly Base Rent Rent Psf 1/1/24-12/31/24 $275,854.50 $22,987.88 $29.50
12/34/56
EX-10.1
from 10-Q 34 pages Aldeyra Therapeutics, Inc. 2023 Equity Incentive Plan
12/34/56
EX-10
from 10-K 7 pages Aldeyra Therapeutics, Inc. 131 Hartwell Avenue, Suite 320 Lexington, Ma 02421 November 26, 2019
12/34/56
EX-10.1911
from 10-K 2 pages Amendment No. 2 to the Offer Letter
12/34/56
EX-10.191
from 10-K 3 pages Amendment No. 1 to the Offer Letter
12/34/56
EX-10.19
from 10-K 6 pages Aldeyra Therapeutics, Inc. 131 Hartwell Avenue, Suite 320 Lexington, Ma 02421 October 21, 2015
12/34/56
EX-10.1
from 10-Q 4 pages Third Amendment to Lease
12/34/56
EX-10.2
from 10-Q 7 pages Aldeyra Therapeutics, Inc. Amended and Restated Change in Control Plan
12/34/56
EX-10.33
from 10-Q 3 pages Second Amendment to Lease
12/34/56
EX-10.32
from 10-Q 10 pages Material contract
12/34/56
EX-10.40
from 10-K 2 pages In Accordance With Item 601(b)(2)(ii) of Regulation S-K, Certain Information (Indicated by “*****”) Has Been Excluded From This Exhibit Because It Is Both Not Material and Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed. Amendment Number 1 and Waiver Agreement to Exclusive License Agreement
12/34/56
EX-10.39
from 10-K 23 pages In Accordance With Item 601(b)(2)(ii) of Regulation S-K, Certain Information (Indicated by “*****”) Has Been Excluded From This Exhibit Because It Is Both Not Material and Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed. Exclusive License Agreement
12/34/56